Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Pigment Cell Melanoma Res. 2016 Mar 15;29(3):297–308. doi: 10.1111/pcmr.12455

Table 2.

Overall survival and recurrence-free survival analysis of mPGES1 expression in patients with stage III

Overall survival
Expression Group N Death (n) HR 95% CI P value
mPGES1 number (N=91) 0 32 26 - - -
1 22 12 0.71 0.36, 1.40 0.32
2 29 19 0.81 0.45, 1.47 0.49
3 8 6 1.24 0.51, 3.02 0.64
mPGES1 intensity (N=91) 0 27 22 - - -
1 33 18 0.68 0.36, 1.27 0.22
2 21 14 0.78 0.40, 1.53 0.48
3 10 9 2.68 1.22, 5.87 0.0141
Recurrence-free survival
Expression Group N Deaths (n) HR 95% CI P value
mPGES1 number (N=91) 0 32 30 - - -
1 22 20 1.16 0.66, 2.05 0.61
2 29 23 0.95 0.55, 1.63 0.84
3 8 7 1.22 0.54, 2.80 0.63
mPGES1 intensity (N=91) 0 27 26 - - -
1 33 28 1.17 0.68, 2.00 0.57
2 21 16 0.84 0.45, 1.58 0.59
3 10 10 2.9 1.37, 6.16 0.0055

Abbreviations: HR, hazards ratio; CI, confidence interval.